Assenagon Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-730,820
| Closed | -$3M | – | 1457 |
|
|
2024
Q1 | $3M | Sell |
730,820
-856,897
| -54% | -$3.52M | 0.01% | 718 |
|
|
2023
Q4 | $6.7M | Hold |
1,587,717
| – | – | 0.02% | 527 |
|
|
2023
Q3 | $6.86M | Hold |
1,587,717
| – | – | 0.02% | 464 |
|
|
2023
Q2 | $10.5M | Hold |
1,587,717
| – | – | 0.04% | 333 |
|
|
2023
Q1 | $10.8M | Hold |
1,587,717
| – | – | 0.04% | 349 |
|
|
2022
Q4 | $11.7M | Sell |
1,587,717
-2,143
| -0.1% | -$15.8K | 0.04% | 323 |
|
|
2022
Q3 | $15.7M | Sell |
1,589,860
-936,620
| -37% | -$9.25M | 0.06% | 251 |
|
|
2022
Q2 | $27.5M | Buy |
2,526,480
+1,195,768
| +90% | +$13M | 0.1% | 165 |
|
|
2022
Q1 | $15.1M | Buy |
1,330,712
+878,492
| +194% | +$9.94M | 0.04% | 259 |
|
|
2021
Q4 | $7.1M | Buy |
452,220
+365,075
| +419% | +$5.73M | 0.02% | 389 |
|
|
2021
Q3 | $1.49M | Buy |
87,145
+15,270
| +21% | +$262K | ﹤0.01% | 745 |
|
|
2021
Q2 | $1.55M | Sell |
71,875
-315,730
| -81% | -$6.79M | 0.01% | 745 |
|
|
2021
Q1 | $5.82M | Sell |
387,605
-113,563
| -23% | -$1.71M | 0.02% | 438 |
|
|
2020
Q4 | $6.59M | Buy |
501,168
+39,984
| +9% | +$525K | 0.03% | 279 |
|
|
2020
Q3 | $4.46M | Sell |
461,184
-6,544
| -1% | -$63.2K | 0.03% | 327 |
|
|
2020
Q2 | $5.35M | Buy |
+467,728
| New | +$5.35M | 0.03% | 296 |
|